Latest News

Imaging Tool Helps Identify Features of Nail Disorders


 

TOPLINE:

Nailfold capillaroscopy identifies distinct changes in capillary density, length, and morphology in patients with conditions such as nail psoriasis, onychomycosis, and retronychia.

METHODOLOGY:

  • The single-center, observational cross-sectional pilot study evaluated patients aged ≥ 7 years with newly diagnosed nail disorders between January 2022 and May 2023.
  • A total of 128 patients (average age, 46.1 years; range, 8-84 years) with nail psoriasis, onychomycosis, idiopathic/traumatic onycholysis, brittle nail syndrome, nail lichen planus, retronychia, and other nail conditions and those with no nail findings (controls) were enrolled.
  • Researchers performed nailfold capillaroscopy imaging and compared capillary features between patients with nail conditions and the controls.

TAKEAWAY:

  • Patients with nail psoriasis had decreased capillary density and length (P < .001), more crossed and tortuous capillaries (P < .02), and increased abnormal capillary morphology (P = .03) compared with controls. Specific abnormalities, such as branching and meandering capillaries, were more common among those with nail psoriasis (both 26.5%).
  • Patients with fingernail and toenail onychomycosis had a higher frequency of abnormal capillary morphology (P < .02), particularly meandering capillaries (75.0% for fingernails and 76.9% for toenails). However, other abnormalities were less frequently observed.
  • Patients with nail lichen planus (P < .01), onychopapilloma (P = .01), and retronychia (P = .03) showed significantly shorter capillaries than controls. Retronychia was also associated with increased disorganized polymorphic capillaries (P = .02).
  • Patients with brittle nail syndrome and eczema showed no significant differences compared with controls.

IN PRACTICE:

“Our findings highlight nailfold capillaroscopy as a potentially quick, cost-effective, and noninvasive imaging modality as an adjunct for diagnosis and treatment initiation for patients with onychodystrophies,” the authors wrote.

SOURCE:

This study was led by Jonathan K. Hwang, MD, Weill Cornell Medicine, New York City, and was published online in The Journal of the American Academy of Dermatology.

LIMITATIONS:

The study’s limitations included a small sample size for certain nail conditions and the single-center design, which limited generalizability. Additionally, the uneven surface, scaling, onycholysis, and thickening of toenails made some capillaroscopy images difficult to capture and interpret.

DISCLOSURES:

The study did not receive any funding. One author reported serving as a consultant for Eli Lilly, Ortho-Dermatologics, BelleTorus, and Moberg Pharma.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication. A version of this article first appeared on Medscape.com.

Recommended Reading

Studies Reinforce JAK Inhibitor Efficacy for Most Challenging Alopecia Types
MDedge Internal Medicine
Hair-Straightening Products Entail Acute Kidney Failure Risk
MDedge Internal Medicine
Androgenetic Alopecia: Study Finds Efficacy of Topical and Oral Minoxidil Similar
MDedge Internal Medicine
Consensus Statement Aims to Guide Use of Low-Dose Oral Minoxidil for Hair Loss
MDedge Internal Medicine
PCOS: Laser, Light Therapy Helpful for Hirsutism
MDedge Internal Medicine
Frontal Fibrosing Alopecia: Study Finds Oral Contraceptive Use Modulates Risk In Women with Genetic Variant
MDedge Internal Medicine
FDA Approves Deuruxolitinib for Severe Alopecia Areata in Adults
MDedge Internal Medicine
Psychiatric, Autoimmune Comorbidities Increased in Patients with Alopecia Areata
MDedge Internal Medicine
Storybooks Can Help Children Deal with Skin Conditions
MDedge Internal Medicine
Metformin Led to Improvements in Women with Central Centrifugal Cicatricial Alopecia
MDedge Internal Medicine